Has elon musk publicly discussed bladder control, incontinence, or related health issues elsewhere?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Elon Musk has not publicly posted a medical record or made detailed, repeated public statements about bladder control or incontinence; multiple news reports say Musk told acquaintances he was using ketamine heavily enough that it affected his bladder, based on a New York Times report that other outlets summarized (e.g., Rolling Stone, Futurism, Times of India) [1] [2] [3]. Medical commentary in secondary coverage warns chronic ketamine use can produce bladder pain, urinary frequency and even incontinence, but available sources do not include a direct on-the-record public quote from Musk explicitly discussing incontinence beyond private remarks reported by others [1] [4].
1. What the reporting actually says: private claim, public reporting
The chain of reporting in mid‑2025 traces a New York Times story that people familiar with Musk’s activities said he told acquaintances he was taking so much ketamine it was “negatively affecting his bladder,” and that assertion was picked up and summarized by outlets such as Rolling Stone, Futurism and the Times of India [1] [2] [3]. Those articles present the claim as sourced to people familiar with Musk, not as a public medical disclosure by Musk himself [1] [3].
2. Medical context cited by the press: ketamine-related bladder injury
The reporting cites medical literature and experts who link chronic ketamine use to a spectrum of urinary harms—urinary pain, reduced bladder capacity, increased pressure, episodes of incontinence and even ureteral or kidney damage—language which Rolling Stone and others paraphrase from studies and clinician commentary [1]. News aggregation and health‑oriented pieces reiterate that chronic, heavy ketamine exposure is associated with serious lower‑urinary‑tract disease [1] [5].
3. Expert reaction reported in the press: doctors’ warnings
Several outlets relayed clinicians saying that if Musk’s bladder problems were caused by ketamine, the pattern implies frequent use; two doctors told the Daily Beast — cited in NewsBreak and Mirror coverage — that doses “multiple times per week” would be consistent with ketamine‑induced bladder damage, and they listed risks including painful urination and episodes of incontinence [4] [6]. These are expert interpretations relayed by secondary outlets, not newly published medical exams of Musk [4].
4. What Musk has publicly said about ketamine in prior appearances
Reporting notes Musk told former CNN host Don Lemon he takes “a small amount” of ketamine once every two weeks as prescribed for depression; that public statement is part of the public record and is the clearest on‑the‑record remark about his ketamine use cited by later coverage [4]. Beyond that, the bladder‑damage claims derive from private‑source reporting, not extended public statements by Musk about bladder control or incontinence [4] [1].
5. Conflicting signals and editorial choices across outlets
Different outlets frame the underlying NYT reporting with varying degrees of emphasis and sensational language — Rolling Stone and Futurism foreground the link between heavy ketamine use and bladder damage, while tabloids and aggregators amplify reaction and commentary [1] [2] [3] [6]. Some pieces include medical caveats; others emphasize salacious detail. The original reporting’s sourcing to “people familiar with” Musk opens space for both critical and conspiratorial takes [1] [3].
6. What’s not supported in available reporting
Available sources do not publish an independent medical diagnosis or records confirming Musk has clinical incontinence; they do not include an on‑the‑record, detailed public admission from Musk that he suffers ongoing incontinence beyond anecdotal statements to acquaintances as reported by the New York Times and summarized elsewhere [1] [3]. Allegations about other bodily matters (penile implants, etc.) are treated as rumors or debunked in separate coverage and are unrelated to verified bladder‑health claims [7] [8].
7. How to weigh the claims: transparency and motive
Journalistic practice requires distinguishing a subject’s on‑the‑record remarks (Musk’s Don Lemon comment about infrequent, small‑dose ketamine) from secondhand accounts sourced to associates. Those secondhand accounts were newsworthy because of Musk’s public profile and because ketamine’s urinary harms are medically established; still, reliance on anonymous or “people familiar” sourcing invites caution about scale and specifics [4] [1]. Outlets with partisan or sensational incentives may amplify worst‑case interpretations; readers should note variations in tone and sourcing across the cited reports [1] [3].
If you want, I can compile the exact quoted language from the New York Times piece and the specific clinician statements that other outlets quoted so you can see the primary phrasings and attributions. Available sources do not mention further public medical disclosures by Musk about bladder control beyond what’s summarized above [1] [4].